학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 80건 | 목록 1~10
Academic Journal
Williams P; Global Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.; Patient Centered Solutions, IQVIA, Courbevoie, France.; Herring TA; Medical Evidence, Epidemiology, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, United States.; Yokota RTC; P95, Epidemiology & Pharmacovigilance, Leuven, Belgium.; Maia T; Patient Centered Solutions, IQVIA, Porto Salvo, Portugal.; Venkatesan S; BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.; Marcus JC; Patient Centered Solutions, IQVIA, Washington, DC, United States.; Settergren G; Global Evidence Portfolio Delivery, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.; Arnetorp S; Health Economic & Payer Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.; Lloyd A; Acaster Lloyd Consulting Ltd, London, United Kingdom.; Severens JL; Severens HTA Consultancy, Venray, Netherlands.; Varni JW; Texas A&M University, College Station, TX, United States.; Dixon S; Patient representative, Sulphur Springs, TX, United States.; Hamusankwa L; Patient representative, London, United Kingdom.; Powell PA; Sheffield Centre for Health and Related Research (SCHARR), University of Sheffield, Sheffield, United Kingdom.; Philip A Powell Consulting, Sheffield, United Kingdom.; Taylor S; Medical Evidence, Vaccine & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.; Ware JE Jr; John Ware Research Group, Watertown, ME, United States.; Krol M; Patient Centered Solutions, IQVIA, Amsterdam, Netherlands.
Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Internet ISSN: 1929-0748 (Electronic) Linking ISSN: 19290748 NLM ISO Abbreviation: JMIR Res Protoc Subsets: MEDLINE
Evans RA; Department of Respiratory Sciences, University of Leicester, Leicester, United Kingdom.; Dube S; AstraZeneca UK Limited, BioPharmaceuticals Medical, Vaccines & Immunotherapies, Eastbrook House, First Floor, Shaftesbury Road, Cambridge, CB2 8DU, United Kingdom.; Lu Y; Evidera, The Ark, 201 Talgarth Road, London, W6 8BJ, United Kingdom.; Yates M; Data Analytics - Real World Evidence, Evidera, London, United Kingdom.; Arnetorp S; Vaccines and Immune Therapies, Global Market Access and Pricing, AstraZeneca R&D, 431 83, Mölndal, Sweden.; Barnes E; Nuffield Department of Medicine, University of Oxford, OUH Hospital NHS Trust, Oxford, United Kingdom.; Bell S; Population Health and Genomics, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, DD1 9SY, Scotland, United Kingdom.; Carty L; Medical and Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.; Evans K; Evidera, Waltham, MA 02451, United States.; Graham S; Evidera, The Ark, 201 Talgarth Road, London, W6 8BJ, United Kingdom.; Justo N; Integrated Solutions - Real World Evidence, Evidera, Stockholm, Sweden.; Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.; University Hospitals Birmingham, NHS Foundation Trust, Birmingham, United Kingdom.; Venkatesan S; Medical and Payer Evidence, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.; Yokota R; P95, Leuven, Belgium.; Ferreira C; AstraZeneca LP, 1800 Concord Pike, Wilmington, DE, 19850-5437, USA.; McNulty R; Medical Affairs, AstraZeneca UK Limited, BioPharmaceuticals Medical, Vaccines & Immunotherapies, Eastbrook House, First Floor, Shaftesbury Road, Cambridge, CB2 8DU, United Kingdom.; Taylor S; Medical Evidence, AstraZeneca UK Limited, BioPharmaceuticals Medical, Vaccines & Immunotherapies, Eastbrook House, First Floor, Shaftesbury Road, Cambridge, CB2 8DU, United Kingdom.; Quint JK; National Heart & Lung Institute, Imperial College London, United Kingdom.
Publisher: [Oxford] Country of Publication: England NLM ID: 101777707 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-7762 (Electronic) Linking ISSN: 26667762 NLM ISO Abbreviation: Lancet Reg Health Eur Subsets: PubMed not MEDLINE
Academic Journal
Attar-Zadeh D; North West London Children & Young People Asthma Network, London, UK darushattar@hotmail.com.; Capstick T; Medicines Management and Pharmacy Services, Leeds Teaching Hospital NHS Trust, Leeds, UK.; Leese D; Sheffield Medicines Optimisation Team, NHS Sheffield Clinical Commissioning Group, Sheffield, UK.; Arnetorp S; Biopharmaceuticals Business Unit, Global Market Access Pricing, Vaccine & Immune Therapy, AstraZeneca, Gothenburg, Sweden.; Rapsomaniki E; Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; Da Costa KP; AI R&D Department, ZS Associates, London, UK.; Maslova E; BioPharmaceutical Medical, Medical Affairs Respiratory and Immunology, AstraZeneca, Cambridge, UK.; Xu Y; BioPharmaceutical Medical, Medical Affairs Respiratory and Immunology, AstraZeneca, Cambridge, UK.; Gibson D; Global Market Access and Pricing, Health Economics and Payer Evidence, AstraZeneca, Cambridge, UK.; Quint JK; National Heart Lung Institute, Imperial College London, London, UK.
Publisher: Royal College of General Practitioners Country of Publication: England NLM ID: 101713531 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2398-3795 (Electronic) Linking ISSN: 23983795 NLM ISO Abbreviation: BJGP Open Subsets: PubMed not MEDLINE
Academic Journal
Kapoor R; Evidera, PPD Singapore, 08-11, 1 Fusionopolis Walk, Singapore 138628, Singapore.; Standaert B; Faculty of Medicine and Life Sciences, University of Hasselt, Agoralaan, 3590 Diepenbeek, Belgium.; Pezalla EJ; Enlightenment Bioconsult, LLC, 140 S Beach Street, Suite 310, Daytona Beach, FL 32114, USA.; Demarteau N; Evidera, 1932 Brussels, Belgium.; Sutton K; Evidera, Melbourne, VIC 3004, Australia.; Tichy E; Evidera, H-1113 Budapest, Hungary.; Bungey G; Evidera, PPD the Ark, 2nd Floor, 201 Talgarth Road, London W6 8BJ, UK.; Arnetorp S; Health Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, 431 83 Gothenberg, Sweden.; Bergenheim K; Health Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, 431 83 Gothenberg, Sweden.; Darroch-Thompson D; International Market Access, Vaccines and Immune Therapies, AstraZeneca, Singapore 339510, Singapore.; Meeraus W; Medical Evidence, Vaccines and Immune Therapies, AstraZeneca, Cambridge CB2 8PA, UK.; Okumura LM; Health Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, São Paulo 06709-000, Brazil.; Tiene de Carvalho Yokota R; Medical Evidence, Vaccines and Immune Therapies, AstraZeneca, Cambridge CB2 8PA, UK.; P95 Epidemiology & Pharmacovigilance, 3001 Leuven, Belgium.; Gani R; Evidera, PPD the Ark, 2nd Floor, 201 Talgarth Road, London W6 8BJ, UK.; Nolan T; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC 3010, Australia.; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Arnetorp, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어